TennCare expanding efforts to acquire deceased beneficiaries' estates

TennCare, Tennessee's Medicaid program, is "stepping up its efforts" to sell deceased beneficiaries' homes to "recoup some of the roughly $1 billion" annually that the state pays for long-term care, the Tennessean reports.

Under state law, the property of deceased individuals can be passed to their heirs without going to probate court.

However, TennCare recently has been petitioning the court to open the estates.

In April, the program hired an outside consulting firm to help find properties that were passed on without going to probate.

In addition, the TennCare Bureau is looking to extend the statute of limitations on petitioning a court to obtain a property.

State officials say they are doing what is required of the federal government, noting that Tennessee is not as aggressive in its pursuit of properties as other states.

Marilyn Wilson, a spokesperson for TennCare, said the acquisitions are "something that we wouldn't be unsympathetic to," adding, "If we are going to provide Medicaid coverage, we must actively engage in estate recovery efforts" (Burke, Tennessean, 10/23).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Expanding access to GLP-1 weight-loss drugs could save thousands of lives